Farmson Pharmaceuticals is a company committed to the research and development of high-quality API that meet the needs of pharmaceutical companies worldwide and inturn patients. With a dedicated R&D center at their facility, the company has a team of experienced scientists who specialize in the development of non-infringing products through multi-scale synthesis spanning from gram to kilo level. For more information visit: https://www.farmson.com/blogs/research-and-development-at-farmson-pharmaceuticals
Farmson was established in the year 1971 for manufacturing of Paracetamol through phenol route. In the year 2000, we switched over to the PNCB route to manufacture Paracetamol. Currently, we are the GLOBAL LEADER in API Paracetamol production.
Subscribe to:
Post Comments (Atom)
Why India is Becoming a Global Hub for Paracetamol API and Caffeine API Manufacturing
India has emerged as one of the world’s most important pharmaceutical manufacturing hubs, particularly in the production of Active Pharmac...
-
Farmson Basic Drugs is expanding beyond paracetamol with a growing portfolio of high-demand APIs across respiratory, cardiovascular, urology...
-
Farmson Basic Drugs leads in Paracetamol DC Granules manufacturing with an EU GMP-certified facility, 3600 MTPA capacity, and advanced GLATT...
-
Farmson Basic Drugs, a leader in API manufacturing, expands its innovation with a world-class synthetic caffeine facility designed for pharm...

No comments:
Post a Comment